<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03177213</url>
  </required_header>
  <id_info>
    <org_study_id>IL-21PV</org_study_id>
    <nct_id>NCT03177213</nct_id>
  </id_info>
  <brief_title>Serum IL-21 Levels in Patients With Pemphigus Vulgaris</brief_title>
  <official_title>Serum IL-21 Levels in Patients With Pemphigus Vulgaris</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pemphigus is severe antigen derived autoimmune bullous skin disorder, the word pemphigus is
      derived from the Greek word&quot; pemphix &quot; which means blister . Two main clinical variants are
      known pemphigus vulgaris (PV), and pemphigu foliaceus (PF). (Zenzo .et al., 2015).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinically, there are localized or generalized flaccid bullae that quickly transform into
      post-bullous erosions and crusts , PV patients characteristically develop oral lesions with
      buccal and/or gingival persisting erosions (mucosal dominant PV) which several weeks or
      months later may also spread to the epidermis (mucocutaneous PV). PF is characterized by
      widespread cutaneous fragile bullae which rapidly rupture, resulting in erosions, crusting,
      and scaling. In contrast to PV, the mucosa is usually not involved in PV. (Zenzo .et al
      .,2015).

      Pathophysiologically, the underlying intraepithelial blister formation is caused by IgG
      autoantibodies against the desmosomal adhesion proteins, desmoglein 3 and/or desmoglein 1, on
      epidermal keratinocytes. ( Amagai .et al .,1991) In PV the antigen is desmoglein 3 which is
      presented in lower epidermis and is expressed more strongly in buccal mucosa than in the skin
      ,in contrast to PF which its antigen is desmoglein 1 which is expressed in the skin
      throughout the epidermis and weakly expressed in the mucous membranes . ( Kneisel and Hertl.
      .,2011).

      T cells play a crucial role in the pathogenesis of pemphigus vulgaris , The interaction of T
      and B cells critically modulates the development of pemphigus vulgaris. (Amber. et al., 2013
      ; Zhu, et al.,2012).

      Because B-cell activation and antibody production classically necessitate the involvement of
      CD4+ T cells, Dsg-reactive T cells were capable of recognizing multiple epitopes of the
      extracellular domain of Dsg and helping B cells to produce a specific antibody. Dsg3-reactive
      T-cell clones were able to commit polyclonal naive B cells to produce pathogenic anti-Dsg3
      antibody and induce the PV phenotype. (Hertl . et al., 1998) Follicular T helper cells (Tfh)
      are a recently discovered group of CD4+ Th cells with intrinsic differences from Th1, Th2 and
      Th17 cells. Localized in B-cell follicles of secondary lymphoid tissues, The major function
      of Tfh cells appears to help B-cell activation and antibody production during humoral immune
      responses. The Tfh cells express high levels of IL-21, which was demonstrated to be important
      for the generation of Tfh cells and that responsiveness of Tfh cells to IL-21 drives the
      formation of the autoimmune reaction, and it clearly impacted on the amount of antibody
      production.( Gomez. et al.,2011 ; Vogelzang . et al.,2008) Nowadays, finding a promising
      treatment for pemphigus remains a serious challenge. Various treatments are currently
      recommended to treat this disease, but they rarely lead to complete and durable remission.
      Regulatory cells appear to have a critical role in numerous autoimmune diseases, so it is
      possible that control of these cells may induce remission. (Cholera and Chainani .,2016)
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>serum IL-21</measure>
    <time_frame>2 months</time_frame>
    <description>serum IL-21 level</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Pemphigus Vulgaris</condition>
  <arm_group>
    <arm_group_label>pemphigus vulgaris patients</arm_group_label>
    <description>20 pemphigus vulgaris patients will be included in the study, either newly diagnosed or recurrent. Patients will be recruited on admission from Dermatology department and Outpatient Clinic, Assiut University Hospitals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <description>10 healthy age and sex matched subjects will be included as controls.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        20 pemphigus vulgaris patients will be included in the study, either newly diagnosed or
        recurrent. Patients will be recruited on admission from Dermatology department and
        Outpatient Clinic, Assiut University Hospitals. 10 healthy age and sex matched subjects
        will be included as controls.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  20 pemphigus vulgaris patients

          -  healthy age and sex matched

        Exclusion Criteria:

          -  - Patients with a history of topical or systemic treatment (corticosteroids,
             intralesional steroid injection, immunosuppressive therapy, anticonvulsants and
             anticancer medications, within 4 weeks of the study.

          -  Patients receiving phototherapy within 6 months of the study .

          -  Patients with a history of diabetes mellitus, anemia, thyroid or parathyroid
             disorders, chronic liver or renal diseases, or atopy .

          -  Patients with known autoimmune diseases or cancer.

          -  Pregnant or lactating women were also excluded from the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hatem Zi Mohammed, Professor</last_name>
    <phone>01003420217</phone>
    <email>zedanhzma@aun.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hanan A Morsy, Doctor</last_name>
    <phone>01064447881</phone>
    <email>hanan_morsy2003@yahoo.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Zhu H, Chen Y, Zhou Y, Wang Y, Zheng J, Pan M. Cognate Th2-B cell interaction is essential for the autoantibody production in pemphigus vulgaris. J Clin Immunol. 2012 Feb;32(1):114-23. doi: 10.1007/s10875-011-9597-4. Epub 2011 Oct 19.</citation>
    <PMID>22009001</PMID>
  </reference>
  <results_reference>
    <citation>Amber KT, Staropoli P, Shiman MI, Elgart GW, Hertl M. Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris. Exp Dermatol. 2013 Nov;22(11):699-704. doi: 10.1111/exd.12229. Review.</citation>
    <PMID>24433179</PMID>
  </results_reference>
  <results_reference>
    <citation>Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell. 1991 Nov 29;67(5):869-77.</citation>
    <PMID>1720352</PMID>
  </results_reference>
  <results_reference>
    <citation>Cholera M, Chainani-Wu N. Management of Pemphigus Vulgaris. Adv Ther. 2016 Jun;33(6):910-58. doi: 10.1007/s12325-016-0343-4. Epub 2016 Jun 10. Review.</citation>
    <PMID>27287854</PMID>
  </results_reference>
  <results_reference>
    <citation>Di Zenzo G, Amber KT, Sayar BS, Müller EJ, Borradori L. Immune response in pemphigus and beyond: progresses and emerging concepts. Semin Immunopathol. 2016 Jan;38(1):57-74. doi: 10.1007/s00281-015-0541-1. Epub 2015 Nov 23. Review.</citation>
    <PMID>26597100</PMID>
  </results_reference>
  <results_reference>
    <citation>Gómez-Martín D, Díaz-Zamudio M, Romo-Tena J, Ibarra-Sánchez MJ, Alcocer-Varela J. Follicular helper T cells poise immune responses to the development of autoimmune pathology. Autoimmun Rev. 2011 Apr;10(6):325-30. doi: 10.1016/j.autrev.2010.11.007. Epub 2010 Dec 15. Review.</citation>
    <PMID>21167320</PMID>
  </results_reference>
  <results_reference>
    <citation>Hertl M, Amagai M, Sundaram H, Stanley J, Ishii K, Katz SI. Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals. J Invest Dermatol. 1998 Jan;110(1):62-6.</citation>
    <PMID>9424089</PMID>
  </results_reference>
  <results_reference>
    <citation>Kneisel A, Hertl M. Autoimmune bullous skin diseases. Part 1: Clinical manifestations. J Dtsch Dermatol Ges. 2011 Oct;9(10):844-56; quiz 857. doi: 10.1111/j.1610-0387.2011.07793.x. Review. English, German.</citation>
    <PMID>21955378</PMID>
  </results_reference>
  <results_reference>
    <citation>Kneisel A, Hertl M. Autoimmune bullous skin diseases. Part 2: diagnosis and therapy. J Dtsch Dermatol Ges. 2011 Nov;9(11):927-47. doi: 10.1111/j.1610-0387.2011.07809.x. Review. English, German.</citation>
    <PMID>22026362</PMID>
  </results_reference>
  <results_reference>
    <citation>Rosenbach M, Murrell DF, Bystryn JC, Dulay S, Dick S, Fakharzadeh S, Hall R, Korman NJ, Lin J, Okawa J, Pandya AG, Payne AS, Rose M, Rubenstein D, Woodley D, Vittorio C, Werth BB, Williams EA, Taylor L, Troxel AB, Werth VP. Reliability and convergent validity of two outcome instruments for pemphigus. J Invest Dermatol. 2009 Oct;129(10):2404-10. doi: 10.1038/jid.2009.72. Epub 2009 Apr 9.</citation>
    <PMID>19357707</PMID>
  </results_reference>
  <results_reference>
    <citation>Vogelzang A, McGuire HM, Yu D, Sprent J, Mackay CR, King C. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity. 2008 Jul 18;29(1):127-37. doi: 10.1016/j.immuni.2008.06.001. Epub 2008 Jul 3.</citation>
    <PMID>18602282</PMID>
  </results_reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2017</study_first_submitted>
  <study_first_submitted_qc>June 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2017</study_first_posted>
  <last_update_submitted>June 4, 2017</last_update_submitted>
  <last_update_submitted_qc>June 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Marwa Kassim</investigator_full_name>
    <investigator_title>AssiutU</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pemphigus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

